Kentucky 2023 Regular Session Status: In Committee

HB 283 — AN ACT relating to coverage for the treatment of postpartum mood disorders.

Last action — to Committee on Committees (H)

  1. ✓
    Introduced
  2. 2
    In Committee
  3. 3
    Passed House
  4. 4
    Passed Senate
  5. 5
    To Executive
  6. 6
    Enacted

This bill died with 2023 Regular Session. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.

This bill is no longer active — its legislative session has ended, so there is no live prognosis. It would have to be reintroduced in the current session to move again.

Summary

Create a new section of Subtitle 17A of KRS Chapter 304 to require health benefit plans to provide coverage for FDA-approved prescription drugs for the treatment of postpartum mood disorders; amend KRS 164.2871, 205.522, 205.6485, and 18A.225 to require a self-insured employer group health plan provided by a state postsecondary education institution to its employees, Medicaid, and Kentucky Children's Health Insurance Program to comply with the new section on postpartum mood disorder coverage; direct that provisions apply to health benefit plans issued on or after the effective date of the section; EFFECTIVE January 1, 2024.

Bill Text

Action History

  1. to Committee on Committees (H)

  2. introduced in House

Sponsorship breakdown

Export CSV (upgrade) →

0 sponsors · 0 co-sponsors · 138 not signed on

Sponsors (0)

None.

Co-sponsors (0)

None.

Not signed on (138)

138 members have not signed on to this bill.

Show all 138 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does HB 283 do?
Create a new section of Subtitle 17A of KRS Chapter 304 to require health benefit plans to provide coverage for FDA-approved prescription drugs for the treatment of postpartum mood disorders; amend KRS 164.2871, 205.522, 205.6485, and 18A.225 to require a self-insured employer group health plan provided by a state postsecondary education institution to its employees, Medicaid, and Kentucky Children's Health Insurance Program to comply with the new section on postpartum mood disorder coverage; direct that provisions apply to health benefit plans issued on or after the effective date of the section; EFFECTIVE January 1, 2024.
What is the current status of HB 283?
This bill died with 2023 Regular Session. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
Where can I track HB 283?
Track HB 283 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on HB 283

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Stay ahead of HB 283

Last checked for changes 2 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →